BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Vuilleumier N, Montecucco F, Hartley O. Autoantibodies to apolipoprotein A-1 as a biomarker of cardiovascular autoimmunity. World J Cardiol 2014; 6(5): 314-326 [PMID: 24944761 DOI: 10.4330/wjc.v6.i5.314]
URL: https://www.wjgnet.com/1949-8462/full/v6/i5/314.htm
Number Citing Articles
1
Fabrizio Montecucco, Elda Favari, Giuseppe Danilo Norata, Nicoletta Ronda, Jerzy-Roch Nofer, Nicolas Vuilleumier. High Density LipoproteinsHandbook of Experimental Pharmacology 2015; 224: 455 doi: 10.1007/978-3-319-09665-0_14
2
Nathalie Satta, Sabrina Pagano, Fabrizio Montecucco, Baris Gencer, François Mach, Laurent Kaiser, Alexandra Calmy, Nicolas Vuilleumier, V. Aubert, J. Barth, M. Battegay, E. Bernasconi, J. Böni, H.C. Bucher, C. Burton-Jeangros, A. Calmy, M. Cavassini, M. Egger, L. Elzi, J. Fehr, J. Fellay, P. Francioli, H. Furrer, C.A. Fux, M. Gorgievski, H. Günthard, D. Haerry, B. Hasse, H.H. Hirsch, B. Hirschel, I. Hösli, C. Kahlert, L. Kaiser, O. Keiser, C. Kind, T. Klimkait, H. Kovari, B. Ledergerber, G. Martinetti, B. Martinez de Tejada, K. Metzner, N. Müller, D. Nadal, G. Pantaleo, A. Rauch, S. Regenass, M. Rickenbach, C. Rudin, P. Schmid, D. Schultze, F. Schöni-Affolter, J. Schüpbach, R. Speck, P. Taffé, P. Tarr, A. Telenti, A. Trkola, P. Vernazza, R. Weber, S. Yerly. Anti-apolipoprotein A-1 autoantibodies are associated with immunodeficiency and systemic inflammation in HIV patientsJournal of Infection 2018; 76(2): 186 doi: 10.1016/j.jinf.2017.11.008
3
Dalia El-Lebedy, Enas Rasheed, Mona Kafoury, Dalia Abd-El Haleem, Eman Awadallah, Ingy Ashmawy. Anti-apolipoprotein A-1 autoantibodies as risk biomarker for cardiovascular diseases in type 2 diabetes mellitusJournal of Diabetes and its Complications 2016; 30(4): 580 doi: 10.1016/j.jdiacomp.2016.02.014
4
Robin P. F. Dullaart, Sabrina Pagano, Frank G. Perton, Nicolas Vuilleumier. Antibodies Against the C-Terminus of ApoA-1 Are Inversely Associated with Cholesterol Efflux Capacity and HDL Metabolism in Subjects with and without Type 2 Diabetes MellitusInternational Journal of Molecular Sciences 2019; 20(3): 732 doi: 10.3390/ijms20030732
5
Aishwarya Sudam Bhale, Krishnan Venkataraman. Leveraging knowledge of HDLs major protein ApoA1: Structure, function, mutations, and potential therapeuticsBiomedicine & Pharmacotherapy 2022; 154: 113634 doi: 10.1016/j.biopha.2022.113634
6
А. Yu. Sidorov, K. V. Fomina, L. V. Beduleva. HDL apoprotein immunization induces T cell-mediated venulitis and inflammation in aortaMedical Immunology (Russia) 2023; 25(3): 637 doi: 10.15789/1563-0625-HAI-2699
7
Tiphaine Mannic, Nathalie Satta, Sabrina Pagano, Magaly Python, Julien Virzi, Fabrizio Montecucco, Miguel A. Frias, Richard W. James, Andres D. Maturana, Michel F. Rossier, Nicolas Vuilleumier. CD14 as a Mediator of the Mineralocorticoid Receptor–Dependent Anti-apolipoprotein A-1 IgG Chronotropic Effect on CardiomyocytesEndocrinology 2015; 156(12): 4707 doi: 10.1210/en.2015-1605
8
Diana Vassallo, Helen Alderson, Nicolas Vuilleumier, James Ritchie, Darren Green, Sabrina Pagano, Julien Virzi, Constantina Chrysochou, Philip A Kalra. Association of novel biomarkers with major clinical outcomes in a cohort of patients with atherosclerotic renovascular diseaseAnnals of Clinical Biochemistry: International Journal of Laboratory Medicine 2019; 56(4): 488 doi: 10.1177/0004563219850850
9
Federico Carbone, Nathalie Satta, Fabrizio Montecucco, Julien Virzi, Fabienne Burger, Aline Roth, Gloria Roversi, Carmine Tamborino, Ilaria Casetta, Silva Seraceni, Alessandro Trentini, Marina Padroni, Franco Dallegri, Patrice H. Lalive, François Mach, Enrico Fainardi, Nicolas Vuilleumier. Anti‐ApoA‐1 IgG serum levels predict worse poststroke outcomesEuropean Journal of Clinical Investigation 2016; 46(9): 805 doi: 10.1111/eci.12664
10
Maria Joao Paiva-Lopes, Joana R. Batuca, Sofia Gouveia, Marta Alves, Ana Luisa Papoila, José Delgado Alves. Antibodies towards high-density lipoprotein components in patients with psoriasisArchives of Dermatological Research 2020; 312(2): 93 doi: 10.1007/s00403-019-01986-x
11
Julia Y. Wang, Wei Zhang, Victor B. Roehrl, Michael W. Roehrl, Michael H. Roehrl. An Autoantigen Atlas From Human Lung HFL1 Cells Offers Clues to Neurological and Diverse Autoimmune Manifestations of COVID-19Frontiers in Immunology 2022; 13 doi: 10.3389/fimmu.2022.831849
12
Elizabeth D. Crane, Ali A. Al-Hashimi, Jack Chen, Edward G. Lynn, Kevin Doyoon Won, Šárka Lhoták, Magda Naeim, Khrystyna Platko, Paul Lebeau, Jae Hyun Byun, Bobby Shayegan, Joan C. Krepinsky, Katey J. Rayner, Serena Marchiò, Renata Pasqualini, Wadih Arap, Richard C. Austin. Anti-GRP78 autoantibodies induce endothelial cell activation and accelerate the development of atherosclerotic lesionsJCI Insight 2018; 3(24) doi: 10.1172/jci.insight.99363
13
Yin Zhang, Heru Zhao, Bin Liu, Li Li, Lulu Zhang, Mei Bao, Xinyu Ji, Xiaojuan He, Jianfeng Yi, Peng Chen, Cheng Lu, Aiping Lu. Low Level Antibodies Against Alpha-Tropomyosin Are Associated With Increased Risk of Coronary Heart DiseaseFrontiers in Pharmacology 2020; 11 doi: 10.3389/fphar.2020.00195
14
Dimitry A Chistiakov, Alexander N Orekhov, Yuri V Bobryshev. ApoA1 and ApoA1-specific self-antibodies in cardiovascular diseaseLaboratory Investigation 2016; 96(7): 708 doi: 10.1038/labinvest.2016.56
15
Michael John Peck, Edward B. Sanders, Gerhard Scherer, Frank Lüdicke, Rolf Weitkunat. Review of biomarkers to assess the effects of switching from cigarettes to modified risk tobacco productsBiomarkers 2018; 23(3): 213 doi: 10.1080/1354750X.2017.1419284
16
I-Jung Tsai, Wen-Chi Shen, Jia-Zhen Wu, Yu-Sheng Chang, Ching-Yu Lin. Autoantibodies to Oxidatively Modified Peptide: Potential Clinical Application in Coronary Artery DiseaseDiagnostics 2022; 12(10): 2269 doi: 10.3390/diagnostics12102269
17
Marie-Laure Santiago-Raber, Fabrizio Montecucco, Nicolas Vuilleumier, Kapka Miteva, Daniela Baptista, Federico Carbone, Sabrina Pagano, Aline Roth, Fabienne Burger, Francois Mach, Karim J. Brandt. Atherosclerotic plaque vulnerability is increased in mouse model of lupusScientific Reports 2020; 10(1) doi: 10.1038/s41598-020-74579-8
18
Zhengda Pang, Akifumi Kushiyama, Jiao Sun, Takako Kikuchi, Hiroki Yamazaki, Yasuhiko Iwamoto, Hiroshi Koriyama, Shota Yoshida, Munehisa Shimamura, Masayoshi Higuchi, Tomohiro Kawano, Yoichi Takami, Hiromi Rakugi, Ryuichi Morishita, Hironori Nakagami. Glial fibrillary acidic protein (GFAP) is a novel biomarker for the prediction of autoimmune diabetesThe FASEB Journal 2017; 31(9): 4053 doi: 10.1096/fj.201700110R
19
Miguel A. Frias, Julien Virzi, Joana Batuca, Sabrina Pagano, Natahlie Satta, Jose Delgado Alves, Nicolas Vuilleumier. ELISA methods comparison for the detection of auto-antibodies against apolipoprotein A1Journal of Immunological Methods 2019; 469: 33 doi: 10.1016/j.jim.2019.03.011
20
Priscila Camillo Teixeira, Philippe Ferber, Nicolas Vuilleumier, Paul Cutler. Biomarkers for cardiovascular risk assessment in autoimmune diseasesPROTEOMICS – Clinical Applications 2015; 9(1-2): 48 doi: 10.1002/prca.201400125
21
Simon H. Bridge, Sabrina Pagano, Meleri Jones, Graham R. Foster, Dermot Neely, Nicolas Vuilleumier, Margaret F. Bassendine. Autoantibody to apolipoprotein A-1 in hepatitis C virus infection: a role in atherosclerosis?Hepatology International 2018; 12(1): 17 doi: 10.1007/s12072-018-9842-5
22
Astrid Malézieux-Picard, Leire Azurmendi, Sabrina Pagano, Nicolas Vuilleumier, Jean-Charles Sanchez, Dina Zekry, Jean-Luc Reny, Jérôme Stirnemann, Nicolas Garin, Virginie Prendki. Role of Clinical Characteristics and Biomarkers at Admission to Predict One-Year Mortality in Elderly Patients with PneumoniaJournal of Clinical Medicine 2021; 11(1): 105 doi: 10.3390/jcm11010105